Q3 FY2026 · ended Sep 30, 2026 · Revenue $1.61B, +8.9% YoY · Filed Nov 3, 2026
Encompass Health Corporation (EHC) files with the SEC under industry code 8060, Services-Hospitals. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $1.6 billion and net income of $149.9 million. Free cash flow was $127.5 million. As of Sep 30, 2026 it held $76.2 million in cash and investments and $2.8 billion in total debt.
Revenue
$1.61B
+8.9% vs year-ago quarter
Net income
$149.90M
+18.5% vs year-ago quarter
Operating cash flow
$362.00M
+33.7% vs year-ago quarter
Free cash flow
$127.50M
+52.3% vs year-ago quarter
EPS
$1.50
+21.0% vs year-ago quarter
Dividend per share
$0.21
+10.5% vs year-ago quarter
Shares outstanding
98.12M
-2.5% vs year-ago quarter
Net cash
$-2.73B
Q3 FY2026
Operating margin
—
Company profile
- Industry
- Services-Hospitals (SIC 8060)
- Listed as
- EHC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Birmingham, AL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 785161
- Former names
- HEALTHSOUTH CORP (until Dec 12, 2017); HEALTHSOUTH REHABILITATION CORP (until Jun 22, 1994)
Other Services-Hospitals companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B |
| Net income | $149.9M | $153.9M | $194.5M | $146.1M | $126.5M |
| Diluted EPS | $1.50 | $1.54 | $1.93 | $1.43 | $1.24 |
| Operating cash flow | $362.0M | $282.6M | $313.1M | $346.0M | $270.8M |
| Free cash flow | $127.5M | $62.3M | $150.7M | $116.7M | $83.7M |
| Total assets | $7.6B | $7.5B | $7.3B | $7.1B | $6.9B |
| Total liabilities | $4.0B | $4.0B | $3.9B | $3.8B | $3.7B |
| Stockholders' equity | $2.7B | $2.6B | $2.5B | $2.4B | $2.4B |
| Cash and investments | $76.2M | $107.7M | $110.5M | $72.2M | $48.7M |
| Total debt | $2.8B | $2.8B | $2.8B | $2.7B | $2.7B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2026 | Nov 6, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
All 1005 Encompass Health Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.